GLP-1 drugs such as Ozempic have, in three short years, changed our attitudes to the body. They’ve revived a cultural fervor for thinness that has been blamed for everything from the closure of wine bars to killing off the body positivity movement. What began as a seeming miracle drug posited to help those most in need of losing weight for health reasons has led to a clamor in which one in eight Americans have tried the drugs and telehealth companies have offered cheaper off-brand versions with very little oversight.
Ozempic (the brand name for semaglutide) and other GLP-1s mimic a natural hormone in the body, stimulating insulin and slowing the rate of stomach emptying after eating, increasing one’s sense of fullness. But the very qualities that make GLP-1s such powerful tools for weight loss also make them potentially dangerous for those who struggle to adequately feed themselves.
